The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
Open accessAbstract
Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel coronavirus (SARS-CoV). SARS-CoV spike (S) protein, a type I membrane-bound protein, is essential for the viral attachment to the host cell receptor angiotensin-converting enzyme 2 (ACE2). By screening 312 controlled Chinese medicinal herbs supervised by Committee on Chinese Medicine and Pharmacy at Taiwan, we identified that three widely used Chinese medicinal herbs of the family Polygonaceae inhibited the interaction of SARS-CoV S protein and ACE2. The IC50 values for Radix et Rhizoma Rhei (the root tubers of Rheum officinale Baill.), Radix Polygoni multiflori (the root tubers of Polygonum multiflorum Thunb.), and Caulis Polygoni multiflori (the vines of P. multiflorum Thunb.) ranged from 1 to 10 μg/ml. Emodin, an anthraquinone compound derived from genus Rheum and Polygonum, significantly blocked the S protein and ACE2 interaction in a dose-dependent manner. It also inhibited the infectivity of S protein-pseudotyped retrovirus to Vero E6 cells. These findings suggested that emodin may be considered as a potential lead therapeutic agent in the treatment of SARS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,026
Bosch, B. J., van der Zee, R., de Haan, C. A. M., & Rottier, P. J. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8801-8811.2003 · Cited by 1,489
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13615-x · Cited by 1,158
Koch's postulates fulfilled for SARS virus
Fouchier, R. A. M., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G. J. J., van den Hoogen, B. G., Peiris, M., Lim, W., Stöhr, K., & Osterhaus, A. D. M. E. (2003) · Nature · doi:10.1038/423240a · Cited by 789
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K., & Nabel, G. J. (2004) · Nature · doi:10.1038/nature02463 · Cited by 665
Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L. J., Wong, S. K., Moore, M. J., Tallarico, A. S. C., Olurinde, M., Choe, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307140101 · Cited by 550
Lin, C.-W., Tsai, F.-J., Tsai, C.-H., Lai, C.-C., Wan, L., Ho, T.-Y., Hsieh, C.-C., & Chao, P.-D. L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.07.002 · Cited by 545
Self-citationSimmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306446101 · Cited by 543
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T., Fan, K. W., Cheng, V. C. C., Tsui, W. H. W., Hung, I. F. N., & Lee, T. S. W. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.003 · Cited by 534
Small molecules targeting severe acute respiratory syndrome human coronavirus
Wu, C.-Y., Jan, J.-T., Ma, S.-H., Kuo, C.-J., Juan, H.-F., Cheng, Y.-S. E., Hsu, H.-H., Huang, H.-C., Wu, D., Brik, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403596101 · Cited by 521
Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11334-11339.2004 · Cited by 485
Self-citationTreatment of SARS with human interferons
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13973-6 · Cited by 467
Chan, K., Lai, S. T., Chu, C., Tsui, E. L. H., Tam, C. Y., Wong, M. M.-L., Tse, M. W., Que, T. L., Peiris, M. J. S., Sung, J. J. �., et al. (2003) · PubMed · Cited by 423
Protein kinase CK2 and its role in cellular proliferation, development and pathology
Guerra, B., & Issinger, O.-G. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990201)20:2<391::aid-elps391>3.0.co;2-n · Cited by 391
Antifungal activity of anthraquinone derivatives from Rheum emodi
Agarwal, S. K., Singh, S. S., Verma, S., & Kumar, S. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00195-1 · Cited by 373
Hofmann, H., Geier, M., Marzi, A., Krumbiegel, M., Peipp, M., Fey, G. H., Gramberg, T., & Pöhlmann, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.114 · Cited by 257
Moore, M. J., Dorfman, T., Li, W., Wong, S. K., Li, Y., Kuhn, J. H., Coderre, J., Vasilieva, N., Han, Z., Greenough, T. C., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10628-10635.2004 · Cited by 243
Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide
Wu, C.-J., Jan, J.-T., Chen, C.-M., Hsieh, H.-P., Hwang, D.-R., Liu, H.-W., Liu, C.-Y., Huang, H.-W., Chen, S.-C., Hong, C.-F., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2693-2696.2004 · Cited by 240
Alves, D. S., Pérez-Fons, L., Estepa, A., & Micol, V. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.012 · Cited by 239
Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
Tan, E. L. C., Ooi, E. E., Lin, C.-Y., Tan, H. C., Ling, A. E., Lim, B., & Stanton, L. W. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1004.030458 · Cited by 237
Chen, Y.-C., Shen, S.-C., Lee, W.-R., Hsu, F.-L., Lin, H.-Y., Ko, C.-H., & Tseng, S.-W. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01386-2 · Cited by 226
Hofmann, H., Hattermann, K., Marzi, A., Gramberg, T., Geier, M., Krumbiegel, M., Kuate, S., Überla, K., Niedrig, M., & Pöhlmann, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6134-6142.2004 · Cited by 199
Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein Core
Tripet, B., Howard, M. W., Jobling, M., Holmes, R. K., Holmes, K. V., & Hodges, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400759200 · Cited by 198
Chen, Z., Zhang, L., Qin, C., Ba, L., Yi, C. E., Zhang, F., Wei, Q., He, T., Yu, W., Yu, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2678-2688.2005 · Cited by 183
Anthraquinones as a new class of antiviral agents against human immunodeficiency virus
Schinazi, R. F., Chu, C. K., Ramesh Babu, J., Oswald, B. J., Saalmann, V., Cannon, D. L., Eriksson, B. F. H., & Nasr, M. (1990) · Antiviral Research · doi:10.1016/0166-3542(90)90071-e · Cited by 178
Barnard, D. L., Huffman, J. H., Morris, J. L. B., Wood, S. G., Hughes, B. G., & Sidwell, R. W. (1992) · Antiviral Research · doi:10.1016/0166-3542(92)90091-i · Cited by 171
Aloe-Emodin Quinone Pretreatment Reduces Acute Liver Injury Induced by Carbon Tetrachloride
Arosio, B., Gagliano, N., Fusaro, L. M. P., Parmeggiani, L., Tagliabue, J., Galetti, P., De Castri, D., Moscheni, C., & Annoni, G. (2000) · Pharmacology and Toxicology · doi:10.1034/j.1600-0773.2000.d01-79.x · Cited by 170
Kumar, A., Dhawan, S., & Aggarwal, B. B. (1998) · Oncogene · doi:10.1038/sj.onc.1201998 · Cited by 163
Sui, J., Li, W., Roberts, A., Matthews, L. J., Murakami, A., Vogel, L., Wong, S. K., Subbarao, K., Farzan, M., & Marasco, W. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.5900-5906.2005 · Cited by 159
Greenough, T. C., Babcock, G. J., Roberts, A., Hernandez, H. J., Thomas, Jr., Coccia, J. A., Graziano, R. F., Srinivasan, M., Lowy, I., Finberg, R. W., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427242 · Cited by 158
Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties
Huei-Chen, H., Chu, S., & Chao, P.-D. L. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90624-y · Cited by 157
Battistutta, R., Sarno, S., Moliner, E. D., Papinutto, E., Zanotti, G., & Pinna, L. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004257200 · Cited by 148
Characterization of viral proteins encoded by the SARS-coronavirus genome
Tan, Y., Lim, S. G., & Hong, W. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.10.001 · Cited by 118
Zhang, X. W., & Yap, Y. L. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.035 · Cited by 98
Effect of integrated traditional Chinese and Western medicine on SARS: A review of clinical evidence
Zhang, M., Liu, X.-M., & He, L. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i23.3500 · Cited by 85
Petit, C. M., Melancon, J. M., Chouljenko, V. N., Colgrove, R., Farzan, M., Knipe, D. M., & Kousoulas, K. G. (2005) · Virology · doi:10.1016/j.virol.2005.06.046 · Cited by 75
Hsiang, C., Wu, S., & Ho, T. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.008 · Cited by 70
Self-citationDevelopment of antiviral therapy for severe acute respiratory syndrome
CINATLJR, J., Michaelis, M., Hoever, G., Preiser, W., & Doerr, H. W. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.03.002 · Cited by 70
Koyama, M., Kelly, T. R., & Watanabe, K. A. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00397a002 · Cited by 63
Yi, C. E., Ba, L., Zhang, L., Ho, D. D., & Chen, Z. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11638-11646.2005 · Cited by 63
HO, T., WU, S., CHEN, J., WEI, Y., CHENG, S., Chang, Y.-J., Liu, H.-Y., & Hsiang, C. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.10.005 · Cited by 62
Self-citationXm, Z., & Qh, C. (1988) · PubMed · Cited by 56
Studies on Rhubarb (Rhei Rhizoma). III. Stilbene Glycosides
Nonaka, G., MINAMI, M., & Nishioka, I. (1977) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.25.2300 · Cited by 40
Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein
Ho, T., Wu, S., Cheng, S., Wei, Y.-C., Huang, S.-P., & Hsiang, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.180 · Cited by 36
Self-citation
Cited by
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0413-9 · Cited by 1,409
COVID‐19 diagnosis and management: a comprehensive review
Pascarella, G., Strumia, A., Piliego, C., Bruno, F., Del Buono, R., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,369
Potential interventions for novel coronavirus in China: A systematic review
Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,348
Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45538 · Cited by 960
Metadata
- Authors
- HO, T., WU, S., CHEN, J., LI, C., & HSIANG, C.
- Venue
- Antiviral Research
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 74
- Issue
- 2
- Pages
- 92-101
- ISSN
- 0166-3542 (ISSN-L)
- OpenAlex
- W2087973684
- Cited by
- 516
- References
- 49
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.